Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in Children.
McFarland EJ, Karron RA, Muresan P, Cunningham CK, Libous J, Perlowski C, Thumar B, Gnanashanmugam D, Moye J, Schappell E, Barr E, Rexroad V, Fearn L, Spector SA, Aziz M, Cielo M, Beneri C, Wiznia A, Luongo C, Collins P, Buchholz UJ.
McFarland EJ, et al. Among authors: luongo c.
J Infect Dis. 2020 Feb 3;221(4):534-543. doi: 10.1093/infdis/jiz603.
J Infect Dis. 2020.
PMID: 31758177
Free PMC article.
Clinical Trial.